192 related articles for article (PubMed ID: 10381785)
1. kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
Vivian JA; DeYoung MB; Sumpter TL; Traynor JR; Lewis JW; Woods JH
J Pharmacol Exp Ther; 1999 Jul; 290(1):259-65. PubMed ID: 10381785
[TBL] [Abstract][Full Text] [Related]
2. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
Craft RM; McNiel DM
Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
[TBL] [Abstract][Full Text] [Related]
3. Systemic effects of E-2078, a stabilized dynorphin A(1-8) analog, in rhesus monkeys.
Butelman ER; Vivian JA; Yu J; Kreek MJ; Woods JH
Psychopharmacology (Berl); 1999 Apr; 143(2):190-6. PubMed ID: 10326782
[TBL] [Abstract][Full Text] [Related]
4. Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy.
Negus SS; Mello NK
J Pharmacol Exp Ther; 2002 Mar; 300(3):1111-21. PubMed ID: 11861822
[TBL] [Abstract][Full Text] [Related]
5. Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.
Carey GJ; Bergman J
J Pharmacol Exp Ther; 2001 Apr; 297(1):215-23. PubMed ID: 11259547
[TBL] [Abstract][Full Text] [Related]
6. Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys.
Butelman ER; Negus SS; Lewis JW; Woods JH
Psychopharmacology (Berl); 1996 Feb; 123(4):320-4. PubMed ID: 8867870
[TBL] [Abstract][Full Text] [Related]
7. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.
Negus SS; Burke TF; Medzihradsky F; Woods JH
J Pharmacol Exp Ther; 1993 Nov; 267(2):896-903. PubMed ID: 8246165
[TBL] [Abstract][Full Text] [Related]
8. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
[TBL] [Abstract][Full Text] [Related]
9. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
10. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
Negus SS; Mello NK
Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
[TBL] [Abstract][Full Text] [Related]
11. Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
Gatch MB; Negus SS; Mello NK; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1282-9. PubMed ID: 8819513
[TBL] [Abstract][Full Text] [Related]
12. Effects of kappa opioid agonists on the discriminative stimulus effects of cocaine in rhesus monkeys.
Negus SS; Mello NK
Exp Clin Psychopharmacol; 1999 Nov; 7(4):307-17. PubMed ID: 10609965
[TBL] [Abstract][Full Text] [Related]
13. Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys.
Butelman ER; Winger G; Zernig G; Woods JH
J Pharmacol Exp Ther; 1995 Feb; 272(2):845-53. PubMed ID: 7853203
[TBL] [Abstract][Full Text] [Related]
14. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
Smith MA; French AM
Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of nalbuphine in rhesus monkeys.
Gerak LR; France CP
J Pharmacol Exp Ther; 1996 Feb; 276(2):523-31. PubMed ID: 8632318
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys.
Ko MC; Butelman ER; Traynor JR; Woods JH
J Pharmacol Exp Ther; 1998 May; 285(2):518-26. PubMed ID: 9580592
[TBL] [Abstract][Full Text] [Related]
17. GR89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys.
Butelman ER; Ko MC; Traynor JR; Vivian JA; Kreek MJ; Woods JH
J Pharmacol Exp Ther; 2001 Sep; 298(3):1049-59. PubMed ID: 11504802
[TBL] [Abstract][Full Text] [Related]
18. kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception.
Butelman ER; Ko MC; Sobczyk-Kojiro K; Mosberg HI; Van Bemmel B; Zernig G; Woods JH
J Pharmacol Exp Ther; 1998 May; 285(2):595-601. PubMed ID: 9580603
[TBL] [Abstract][Full Text] [Related]
19. Kappa opioids in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and beta-funaltrexamine.
Dykstra LA; Gmerek DE; Winger G; Woods JH
J Pharmacol Exp Ther; 1987 Aug; 242(2):421-7. PubMed ID: 3302207
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the mu and kappa opioid actions of butorphanol in humans through differential naltrexone blockade.
Walsh SL; Chausmer AE; Strain EC; Bigelow GE
Psychopharmacology (Berl); 2008 Jan; 196(1):143-55. PubMed ID: 17909753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
